Human IAPP–induced pancreatic β cell toxicity and its regulation by autophagy
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
Pancreatic islets in patients with type 2 diabetes mellitus (T2DM) are characterized by loss of β cells and formation of amyloid deposits derived from islet amyloid polypeptide (IAPP). Here we demonstrated that treatment of INS-1 cells with human IAPP (hIAPP) enhances cell death, inhibits cytoproliferation, and increases autophagosome formation. Furthermore, inhibition of autophagy increased the vulnerability of β cells to the cytotoxic effects of hIAPP. Based on these in vitro findings, we examined the pathogenic role of hIAPP and its relation to autophagy in hIAPP-knockin mice. In animals fed a standard diet, hIAPP had no toxic effects on β cell function; however, hIAPP-knockin mice did not exhibit a high-fat-diet-induced compensatory increase in β cell mass, which was due to limited β cell proliferation and enhanced β cell apoptosis. Importantly, expression of hIAPP in mice with a β cell-specific autophagy defect resulted in substantial deterioration of glucose tolerance and dispersed cytoplasmic expression of p62-associated toxic oligomers, which were otherwise sequestrated within p62-positive inclusions. Together, our results indicate that increased insulin resistance in combination with reduced autophagy may enhance the toxic potential of hIAPP and enhance β cell dysfunction and progression of T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been elucidated that beta-cells are usually protected from IAPP oligomers by autophagy processes, so it seems that these processes are defective in prediabetes and T2D, which is likely pivotal for the pathogenesis of T2D.128,132”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [132]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been elucidated that beta-cells are usually protected from IAPP oligomers by autophagy processes, so it seems that these processes are defective in prediabetes and T2D, which is likely pivotal for the pathogenesis of T2D.128,132”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [132]
Experimental — accuracy not yet measuredIn the citing paper
“It has been elucidated that beta-cells are usually protected from IAPP oligomers by autophagy processes, so it seems that these processes are defective in prediabetes and T2D, which is likely pivotal for the pathogenesis of T2D.128,132”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 2×
“The use of standard diet up to 20 weeks of age Autophagy is a cellular protein degradation system and plays a crucial role in intracellular quality control by eliminating damaged organelles and toxic proteins (20–22).”
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 2×
“To explore such a scenario, we investigated the presence of toxic oligomers in hIAPP-knockin islets using A11 antibody, which recognizes a backbone peptide epitope common to amyloid oligomers (41, 42).”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276 · cited 3×
“…Yoshimori, 2,7 Norman L. Eberhardt, 5 Yoshio Fujitani, 1,2,3 and Hirotaka Watada 1,3,4,8,9 known as SQSTM1), a specific substrate for autophagy (32–34), was not affected (Figure 1C and Supplemental Figure 3), which suggests that increased LC3-II levels were probably due to increased autophagic…”
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206 · cited 1×
“Recombinant adenoviruses expressing hIAPP and rIAPP were prepared using the AdEasy system (60).”
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331
Self-citationKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124
Self-citationBoland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967
Self-citationPancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820 · cited 1×
“Several studies have demonstrated that hIAPP induces β cell apoptosis (8, 9, 29, 30).”
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807 · cited 3×
“In addition, the 20–29 region is homologous among humans, cats, and monkeys and is hydrophobic and amyloidogenic (8, 9, 11).”
Structural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · cited 2×
“To explore such a scenario, we investigated the presence of toxic oligomers in hIAPP-knockin islets using A11 antibody, which recognizes a backbone peptide epitope common to amyloid oligomers (41, 42).”
Ebato, C., Uchida, T., Arakawa, M., Komatsu, M., Ueno, T., Komiya, K., Azuma, K., Hirose, T., Tanaka, K., Kominami, E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.009 · Cited by 774 · cited 10×
“We reported previously that high-fat diet feeding upregulated autophagic vacuole formation in pancreatic β cells in response to increased insulin resistance (26).”
InfluentialSelf-citationPancreatic β‐cell mass in European subjects with type 2 diabetes
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C., & Henquin, J. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00969.x · Cited by 756
Loss of Autophagy Diminishes Pancreatic β Cell Mass and Function with Resultant Hyperglycemia
Jung, H. S., Chung, K. W., Won Kim, J., Kim, J., Komatsu, M., Tanaka, K., Nguyen, Y. H., Kang, T. M., Yoon, K.-H., Kim, J.-W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.013 · Cited by 647 · cited 2×
“Our observations suggested that hIAPP is not intrinsically cytotoxic, but behaves as a susceptibility factor for human T2DM together with other risk factors for diabetes, such as insulin resistance, high-fat feeding, and/or reduced autophagy (26, 27).”
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612 · cited 2×
“These observations were in agreement with the recent concept that soluble intracellular and extracellular toxic oligomers of hIAPP, rather than insoluble amyloid, may be responsible for the hIAPP-induced β cell toxicity (9, 40, 51, 52).”
Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583 · cited 2×
“Amyloid deposition is the hallmark of human diabetic islets (7, 8).”
Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus Revisited
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. U. (1985) · Pathology and Immunopathology Research · doi:10.1159/000156969 · Cited by 577 · cited 1×
“Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and β cell failure (1); the latter is caused by reduction in β cell function (2, 3) and β cell mass (4–6).”
Atomic View of a Toxic Amyloid Small Oligomer
Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., et al. (2012) · Science · doi:10.1126/science.1213151 · Cited by 563 · cited 1×
“A11 is a conformationally specific antibody that recognizes a subset of toxic oligomers in a wide range of amyloid diseases (41, 42, 53).”
BRUNZELL, J. D., ROBERTSON, R. P., LERNER, R. L., HAZZARD, W. R., ENSINCK, J. W., BIERMAN, E. L., & PORTE, D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-2-222 · Cited by 505 · cited 1×
“org Volume 124 Number 8 August 2014 Introduction Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and β cell failure (1); the latter is caused by reduction in β cell function (2, 3) and β cell mass (4–6).”
p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding
Itakura, E., & Mizushima, N. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009067 · Cited by 416 · cited 1×
“Formation of ubiquitin-positive cytoplasmic inclusions depends on the PB1 and UBA domains of p62, given that it is able to polymerize via its N-terminal PB1 domain and to recognize polyubiquitin via its C-terminal UBA domain (32, 58, 59).”
Huang, C.-J., Lin, C.-Y., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db07-0197 · Cited by 416
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 342 · cited 3×
“In contrast to the results obtained by in vitro overexpression and transgenic overexpression of hIAPP (15, 18, 19), expression of WT hIAPP in the knockin mouse model failed to induce islet amyloid formation; rather, it induced mild glucose intolerance (17), which suggests that hIAPP-knockin mice…”
p62/SQSTM1: A Missing Link between Protein Aggregates and the Autophagy Machinery
Bjørkøy, G., Lamark, T., & Johansen, T. (2006) · Autophagy · doi:10.4161/auto.2.2.2405 · Cited by 322
Conditional Gene Targeting in Mouse Pancreatic β-Cells
Wicksteed, B., Brissova, M., Yan, W., Opland, D. M., Plank, J. L., Reinert, R. B., Dickson, L. M., Tamarina, N. A., Philipson, L. H., Shostak, A., et al. (2010) · Diabetes · doi:10.2337/db10-0624 · Cited by 321
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
p62/SQSTM1/A170: Physiology and pathology
Komatsu, M., Kageyama, S., & Ichimura, Y. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.004 · Cited by 300 · cited 3×
“…Yoshimori, 2,7 Norman L. Eberhardt, 5 Yoshio Fujitani, 1,2,3 and Hirotaka Watada 1,3,4,8,9 known as SQSTM1), a specific substrate for autophagy (32–34), was not affected (Figure 1C and Supplemental Figure 3), which suggests that increased LC3-II levels were probably due to increased autophagic…”
Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278 · cited 1×
“To investigate the role of hIAPP, several mouse models and a rat model transgenic for hIAPP have been developed (13–16).”
Butler, A. E., Jang, J., Gurlo, T., Carty, M. D., Soeller, W. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1509 · Cited by 267
Aggregate‐Prone Proteins Are Cleared from the Cytosol by Autophagy: Therapeutic Implications
Williams, A., Jahreiss, L., Sarkar, S., Saiki, S., Menzies, F. M., Ravikumar, B., & Rubinsztein, D. C. (2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76003-3 · Cited by 239 · cited 2×
“The use of standard diet up to 20 weeks of age Autophagy is a cellular protein degradation system and plays a crucial role in intracellular quality control by eliminating damaged organelles and toxic proteins (20–22).”
Amylin Agonists: A Novel Approach in the Treatment of Diabetes
Schmitz, O., Brock, B., & Rungby, J. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s233 · Cited by 239 · cited 1×
“While mouse IAPP intrinsically functions as a satiety factor acting on the CNS, such function is probably less active with hIAPP, based on its aggrega-tion-prone properties (49).”
The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance
Tamaki, M., Fujitani, Y., Hara, A., Uchida, T., Tamura, Y., Takeno, K., Kawaguchi, M., Watanabe, T., Ogihara, T., Fukunaka, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68807 · Cited by 238
Self-citationBeta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes
Miklossy, J., Qing, H., Radenovic, A., Kis, A., Vileno, B., Làszló, F., Miller, L., Martins, R. N., Waeber, G., Mooser, V., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.019 · Cited by 235
Evidence for Proteotoxicity in β Cells in Type 2 Diabetes
Gurlo, T., Ryazantsev, S., Huang, C.-J., Yeh, M. W., Reber, H. A., Hines, O. J., O'Brien, T. D., Glabe, C. G., & Butler, P. C. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090532 · Cited by 228 · cited 1×
“In contrast, overexpression of hIAPP in vitro or in vivo by a transgenic approach uncovered a broad range of toxic properties for hIAPP on β cells, including induction of apoptosis (5, 14, 43), amyloidogenesis (14, 15, 44), mitochondrial dysfunction (45), and inhibition of GSIS (46), possibly due to a nonselective tox…”
Abstracts of the IDF Congress in Paris 2003
(2003) · Diabetologia · doi:10.1007/s00125-003-1190-9 · Cited by 211
Hartter, E., Svoboda, T., Ludvik, B., Schuller, M., Lell, B., Kuenburg, E., Brunnbauer, M., Woloszczuk, W., & Prager, R. (1991) · Diabetologia · doi:10.1007/bf00404025 · Cited by 191 · cited 1×
“The major constituent of islet amyloid in humans is derived from islet amyloid polypeptide (IAPP; also known as amylin), a 37–amino acid polypeptide synthesized in pancreatic β cells and coreleased with insulin in response to a rise in blood glucose level (8, 10).”
Zraika, S., Hull, R. L., Verchere, C. B., Clark, A., Potter, K. J., Fraser, P. E., Raleigh, D. P., & Kahn, S. E. (2010) · Diabetologia · doi:10.1007/s00125-010-1671-6 · Cited by 179 · cited 1×
“These observations were in agreement with the recent concept that soluble intracellular and extracellular toxic oligomers of hIAPP, rather than insoluble amyloid, may be responsible for the hIAPP-induced β cell toxicity (9, 40, 51, 52).”
Betsholtz, C., Christmansson, L., Engström, U., Rorsman, F., Svensson, V., Johnson, K. H., & Westermark, P. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81467-x · Cited by 176 · cited 1×
“In contrast, in mouse IAPP, the 20–29 region has proline substitutions compared with human IAPP (hIAPP), and, as a result, mouse IAPP is soluble and nonamyloidogenic (8, 9, 11, 12).”
Meier, J. J., Kayed, R., Lin, C.-Y., Gurlo, T., Haataja, L., Jayasinghe, S., Langen, R., Glabe, C. G., & Butler, P. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00082.2006 · Cited by 166
Multiple Pathways of TWEAK-Induced Cell Death
Nakayama, M., Ishidoh, K., Kayagaki, N., Kojima, Y., Yamaguchi, N., Nakano, H., Kominami, E., Okumura, K., & Yagita, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.734 · Cited by 164
Sakagashira, S., Hiddinga, H. J., Tateishi, K., Sanke, T., Hanabusa, T., Nanjo, K., & Eberhardt, N. L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64848-1 · Cited by 156
Self-citationIslet Amyloid Polypeptide (IAPP) Transgenic Rodents as Models for Type 2 Diabetes
Matveyenko, A. V., & Butler, P. C. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.225 · Cited by 150 · cited 3×
“In contrast to the previously described transgenic models for hIAPP (13–15), hIAPP-knockin mice remained healthy and showed normal glucose tolerance as long as they were fed standard diet.”
Rivera, J. F., Gurlo, T., Daval, M., Huang, C. J., Matveyenko, A. V., Butler, P. C., & Costes, S. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.111 · Cited by 150
Paulsson, J. F., Andersson, A., Westermark, P., & Westermark, G. T. (2006) · Diabetologia · doi:10.1007/s00125-006-0206-7 · Cited by 133
β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
Costes, S., Langen, R., Gurlo, T., Matveyenko, A. V., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1326 · Cited by 123 · cited 8×
“IAPP exhibits close amino acid homology in the N-and C-terminal regions in all species studied (9, 11).”
InfluentialQuan, W., Kim, H.-K., Moon, E.-Y., Kim, S. S., Choi, C. S., Komatsu, M., Jeong, Y. T., Lee, M.-K., Kim, K.-W., Kim, M.-S., et al. (2012) · Endocrinology · doi:10.1210/en.2011-1882 · Cited by 117
O'Brien, T. D., Butler, P. C., Westermark, P., & Johnson, K. H. (1993) · Veterinary Pathology · doi:10.1177/030098589303000401 · Cited by 115 · cited 6×
“The major constituent of islet amyloid in humans is derived from islet amyloid polypeptide (IAPP; also known as amylin), a 37–amino acid polypeptide synthesized in pancreatic β cells and coreleased with insulin in response to a rise in blood glucose level (8, 10).”
InfluentialSteneberg, P., Bernardo, L., Edfalk, S., Lundberg, L., Backlund, F., Östenson, C.-G., & Edlund, H. (2013) · Diabetes · doi:10.2337/db12-1045 · Cited by 106
Autophagy and neurodegeneration
Ventruti, A., & Cuervo, A. M. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0068-5 · Cited by 95
Pancreatic Expression and Secretion of Human Islet Amyloid Polypeptide in a Transgenic Mouse
D'Alessio, D. A., Verchere, C. B., Kahn, S. E., Hoagland, V., Baskin, D. G., Palmiter, R. D., & Ensinck, J. W. (1994) · Diabetes · doi:10.2337/diab.43.12.1457 · Cited by 93 · cited 1×
“In contrast to the results obtained by in vitro overexpression and transgenic overexpression of hIAPP (15, 18, 19), expression of WT hIAPP in the knockin mouse model failed to induce islet amyloid formation; rather, it induced mild glucose intolerance (17), which suggests that hIAPP-knockin mice…”
Intracellular Amyloidogenesis by Human Islet Amyloid Polypeptide Induces Apoptosis in COS-1 Cells
Hiddinga, H. J., & Eberhardt, N. L. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65360-6 · Cited by 81
Self-citationFukunaka, A., Kurokawa, Y., Teranishi, F., Sekler, I., Oda, K., Ackland, M. L., Faundez, V., Hiromura, M., Masuda, S., Nagao, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227173 · Cited by 73 · cited 1×
“Immunostaining was performed as described previously (63).”
Self-citationAccumulation of β-Amyloid fibrils in pancreas of transgenic mice
Kawarabayashi, T., Shoji, M., Sato, M., Sasaki, A., Ho, L., Eckman, C. B., Prada, C.-M., Younkin, S. G., Kobayashi, T., Tada, N., et al. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02061-6 · Cited by 73
Exendin-4 Improves β-Cell Function in Autophagy-Deficient β-Cells
Abe, H., Uchida, T., Hara, A., Mizukami, H., Komiya, K., Koike, M., Shigihara, N., Toyofuku, Y., Ogihara, T., Uchiyama, Y., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1578 · Cited by 71
Self-citationHuman islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.
O’Brien, T. D., Butler, P. C., Kreutter, D. K., Kane, L. A., & Eberhardt, N. L. (1995) · Europe PMC (PubMed Central) · Cited by 65
Self-citationÅhrén, B., Oosterwijk, C., Lips, C. J. M., & Höppener, J. W. M. (1998) · Diabetologia · doi:10.1007/s001250051079 · Cited by 48 · cited 1×
“In contrast, overexpression of hIAPP in vitro or in vivo by a transgenic approach uncovered a broad range of toxic properties for hIAPP on β cells, including induction of apoptosis (5, 14, 43), amyloidogenesis (14, 15, 44), mitochondrial dysfunction (45), and inhibition of GSIS (46), possibly due to a nonselective tox…”
Autophagy protects against human islet amyloid polypeptide‐associated apoptosis
Morita, S., Sakagashira, S., Shimajiri, Y., Eberhardt, N. L., Kondo, T., Kondo, T., & Sanke, T. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00065.x · Cited by 36
Self-citationGamma-protocadherins regulate the functional integrity of hypothalamic feeding circuitry in mice
Su, H., Marcheva, B., Meng, S., Liang, F. A., Kohsaka, A., Kobayashi, Y., Xu, A. W., Bass, J. T., & Wang, X. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.12.010 · Cited by 29 · cited 2×
“Due to misexpression of RIP-Cre in the hypothalamus (48), RIP-mediated Atg7 deletion might have caused increased food intake and obesity with high-fat diet feeding (36, 37).”
Isolating Toxic Insulin Amyloid Reactive Species that Lack β-Sheets and Have Wide pH Stability
Heldt, C. L., Kurouski, D., Sorci, M., Grafeld, E., Lednev, I. K., & Belfort, G. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.04.046 · Cited by 25
Hiddinga, H. J., Sakagashira, S., Ishigame, M., Madde, P., Sanke, T., Nanjo, K., Kudva, Y. C., Lee, J. J., van Deursen, J., & Eberhardt, N. L. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00166.x · Cited by 13
Self-citation
Research works printed but not linked: 2
- Kloppel, 1985, Surv Synth Pathol Res., 4, 110
- O’Brien, 1995, Am J Pathol., 147, 609
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Autophagy in metabolic disease and ageing
Kitada, M., & Koya, D. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00551-9 · Cited by 399
Metadata
- Authors
- Shigihara, N., Fukunaka, A., Hara, A., Komiya, K., Honda, A., Uchida, T., Abe, H., Toyofuku, Y., Tamaki, M., Ogihara, T., Miyatsuka, T., Hiddinga, H. J., Sakagashira, S., Koike, M., Uchiyama, Y., Yoshimori, T., Eberhardt, N. L., Fujitani, Y., & Watada, H.
- Affiliations
- Japan Science and Technology Agency (JP)
- Juntendo University (JP)
- Mayo Clinic (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-07-18
- Volume
- 124
- Issue
- 8
- Pages
- 3634-3644
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4109539
- OpenAlex
- W2157104650
- Cited by
- 177
- References
- 65
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 15 · 2021: 25 · 2020: 12 · 2019: 12 · 2018: 22 · 2017: 11 · 2016: 19 · 2015: 18 · 2014: 4
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (26860700, 26251020, 25460276, 26111519, 26293220)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- amylin, autophagy, type 2 diabetes, beta-cell apoptosis, beta-cell proliferation, autophagosome formation, p62, high-fat diet, glucose tolerance, insulin resistance, beta-cell dysfunction, INS-1 cells
- MeSH terms
- Autophagy-Related Protein 7, Animals, Autophagy, Cell Cycle, Cell Line, Cell Survival, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Mice, Transgenic, Microtubule-Associated Proteins, Recombinant Proteins, Mice, Knockout, Insulin-Secreting Cells, Mice, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.